
handle: 11390/1132341
New approaches in the diagnosis and therapy of myopic Choroidal neovascularization (CNV). Long-tem effects of anti-VEGF therapy for subfoveal myopic CNV. Best treatment drug: Bevacizumab versus Ranibizumab. Effects of treatment regimen. Effects of myopic CNV location (Juxtafoveal versus Extrafoveal myopic CNV). Agreement between FA and spectral domain OCT in detecting the activity of myopic subfoveal CNV
Myopia; Choroidal neovascularization; Anti-VEGF therapy
Myopia; Choroidal neovascularization; Anti-VEGF therapy
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
